{"created_at":"Mon Jul 20 18:47:33 +0000 2015","id":623202602604457984,"id_str":"623202602604457984","text":"RT @JohnCFierce: Alirocumab headed for a likely approval, pdufa on Friday. Maybe Repatha as well?\n$SNY $REGN $AMGN","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":402969893,"id_str":"402969893","name":"Michael O'Riordan","screen_name":"mikeheartwire","location":"","url":"http:\/\/theheart.org","description":"Medical journalist with @theheartorg since 2003. Likes running marathons and vegetarian food. Dislikes snow, flat (bike) tires, and stress fractures.","protected":false,"verified":false,"followers_count":1387,"friends_count":594,"listed_count":59,"favourites_count":32,"statuses_count":1958,"created_at":"Tue Nov 01 20:51:04 +0000 2011","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"B91300","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/358302739\/twitter-theheartorg-v1.png","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/358302739\/twitter-theheartorg-v1.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DFDFDF","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000670296169\/7a85e284b3ce32fb45cfd918d5bc9ca8_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000670296169\/7a85e284b3ce32fb45cfd918d5bc9ca8_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/402969893\/1401723134","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Mon Jul 20 16:03:25 +0000 2015","id":623161294934405120,"id_str":"623161294934405120","text":"Alirocumab headed for a likely approval, pdufa on Friday. Maybe Repatha as well?\n$SNY $REGN $AMGN","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":102754598,"id_str":"102754598","name":"John Carroll","screen_name":"JohnCFierce","location":"Dorset, VT","url":"http:\/\/www.fiercebiotech.com","description":"John Carroll is the editor of FierceBiotech (12 years) and EIC of the life sciences group @Fierce. Online business journalism demands a new style.","protected":false,"verified":false,"followers_count":20323,"friends_count":396,"listed_count":739,"favourites_count":22,"statuses_count":17675,"created_at":"Thu Jan 07 18:33:18 +0000 2010","utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/558676395597889536\/0J3-iJDB_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/558676395597889536\/0J3-iJDB_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":7,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"SNY","indices":[81,85]},{"text":"REGN","indices":[86,91]},{"text":"AMGN","indices":[92,97]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"JohnCFierce","name":"John Carroll","id":102754598,"id_str":"102754598","indices":[3,15]}],"symbols":[{"text":"SNY","indices":[98,102]},{"text":"REGN","indices":[103,108]},{"text":"AMGN","indices":[109,114]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1437418053662"}
